#depression
Latest news and interesting information about depression.
Mental disorders double worldwide
Global mental disorder rates have doubled in 30 years, reaching 1.17 billion. The Lancet study highlights depression and schizophrenia surges.
Wolfe Research Starts Alto Neuroscience with Outperform
Wolfe Research initiates coverage on Alto Neuroscience with an outperform rating and $35 price target. ALTO-207 pipeline highlighted.
Bernstein Initiates Neurocrine with Outperform Rating
Bernstein initiates Neurocrine Biosciences with an outperform rating and $221 price target. Highlights Crenessity's potential and stock upside.
5 Signs of Emotional Burnout
5 key signs of emotional burnout: irritability, fatigue, emptiness, cynicism, loss of empathy. When to see a doctor?
"Wegovy" aids weight loss in menopause
"Wegovy" effectively supports weight loss and heart health in menopausal women.
Canaccord Reaffirms GH Research Stock Rating on Phase 3 Progress
Canaccord Genuity keeps Buy rating on GH Research stock as Phase 3 program for GH001 advances. Key financial highlights included.
...